The FDA’s mention of the regulatory agenda serves as a reminder that federal agencies under the Trump administration have yet to publish their annual spring update, information typically posted before May.

The current update available online from the White House Office of Management and Budget’s Office of Information and Regulatory Affairs was published in December.

Additionally, the “Agency Statements of Regulatory Priorities” available from the office are statements provided by the agencies during the Biden administration. The Department of Health and Human Services provides a clear example of the different priorities federal agencies stated before President Trump began his second term.

Priorities for fiscal year 2024 explained in the HHS document include the categories Reducing Disparities and Advancing Equity; Increasing Public Health Preparedness; and Enhancing coverage and access in the ACA Marketplaces, Medicaid, CHIP, and Medicare over goals including::

Expanding opportunities for children and youth to thrive;
Strengthening health and safety standards for consumer products, including those that disproportionately impact underserved communities;
Improving access to safe and nutritious food;
Preventing and remedying discrimination;
Promoting equity in federally supported health care services.

US FDA Has Lists To Assure Progress On Supplement Sector Regulations, NDIN Guidance

More from Regulation

More from Policy & Regulation